Skip to main content
. 2016 Jul 8;95(27):e3845. doi: 10.1097/MD.0000000000003845

Figure 4.

Figure 4

Meta-analysis of dropout from the study due to adverse events comparing degarelix versus GnRH agonists therapy groups.

HHS Vulnerability Disclosure